Patents by Inventor Josef Mannhalter

Josef Mannhalter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for isolating IgG and IgA
    Patent number: 6646108
    Abstract: A method for the separation of IgG and IgA from an immunoglobulin-containing starting material is described, whereby the method is characterized in that (i) IgG and optionally IgA are adsorbed to a solid inorganic carrier material, (ii) IgA is isolated from the eluate, optionally after selective desorption, whereas IgG remains on the carrier material, and optionally (iii) IgG is isolated from the adsorbate. Furthermore, an IgA preparation is disclosed which demonstrates a low tendency to form aggregates.
    Type: Grant
    Filed: July 9, 1998
    Date of Patent: November 11, 2003
    Assignee: Baxter Aktiengesellschaft
    Inventors: Heinz Leibl, Regine Tomasits, Josef Mannhalter, Hermann Wolf, Martha Eibl
  • Cell-based vaccine
    Publication number: 20030103996
    Abstract: The invention relates to a complex comprising an antigen of a microbial or molecular pathogen and mammalian cell constituents in isolated or purified form. A vaccine composition containing the complex, a corresponding pharmaceutical preparation and a method of preparing the complex are also disclosed.
    Type: Application
    Filed: September 26, 2002
    Publication date: June 5, 2003
    Inventors: Martha Eibl, Thomas Kreil, Josef Mannhalter, Johann Eibl, Astrid Kerschbaum, Peter Bruhl
  • Adjuvant based on colloidal iron compounds
    Patent number: 5895653
    Abstract: An adjuvant is described which comprises an iron compound in colloidal form as well as a pharmaceutical composition which comprises this adjuvant together with at least a protein and/or peptide and/or polysaccharide and/or a nucleic acid derived from a virus, bacterium and/or a parasite.The adjuvant according to the invention and the pharmaceutical composition comprising this adjuvant are suitable for prophylactic or therapeutic treatment of illnesses caused by various pathogens.
    Type: Grant
    Filed: March 26, 1996
    Date of Patent: April 20, 1999
    Assignee: Tempo G
    Inventors: Johann Eibl, Heinz Leibl, Josef Mannhalter